Q9BXP5 (SRRT_HUMAN) Homo sapiens (Human)
Serrate RNA effector molecule homolog UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
6 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Crystal structure of Human ARS2 residues 147-270 + 408-763 with deletion of loop B |
Heteromer | |||||
| Assess | ||||||
| Crystal structure of Human ARS2 residues 147-270 + 408-763 |
Heteromer | |||||
| Assess | ||||||
| Crystal structure of Human ARS2 residues 171-270 + 408-763 |
Heteromer | |||||
| Assess | ||||||
| Crystal structure of Human ARS2 residues 171-270 + 408-763 (P65 form) |
Heteromer | |||||
| Assess | ||||||
| Structure of the human nuclear cap-binding complex bound to ARS2[147-871] and m7GTP |
Heteromer P52298; Q09161; | 1×MGT; | ||||
| Assess | ||||||
| Complex of human nuclear cap-binding complex with ARS2 C-terminal peptide |
Heteromer P52298; Q09161; | 1×MGT; | ||||
| Assess | ||||||
2 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 6f7j.1.B | monomer | 0.75 | 100.00 | |||
| Assess | ||||||
| 8pmp.1.C | monomer | 0.67 | 100.00 | |||
| Assess | ||||||
8 SWISS-MODEL models built on isoform sequence
| Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | 6f7j.1.B | monomer | 0.75 | 100.00 | ||
| Assess | ||||||
| Isoform 2 | 8pmp.1.C | monomer | 0.64 | 99.86 | ||
| Assess | ||||||
| Isoform 3 | 6f7j.1.B | monomer | 0.75 | 100.00 | ||
| Assess | ||||||
| Isoform 3 | 8pmp.1.C | monomer | 0.64 | 100.00 | ||
| Assess | ||||||
| Isoform 4 | 6f7j.1.B | monomer | 0.75 | 100.00 | ||
| Assess | ||||||
| Isoform 4 | 8pmp.1.C | monomer | 0.62 | 99.72 | ||
| Assess | ||||||
| Isoform 5 | 6f7j.1.B | monomer | 0.73 | 100.00 | ||
| Assess | ||||||
| Isoform 5 | 8pmp.1.C | monomer | 0.63 | 99.86 | ||
| Assess | ||||||